Newark, New Castle, USA, March 01, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Global Peptide Therapeutics Market by Application (Metabolic, Cardiovascular Disorder, Respiratory, Cancers, GIT, Anti-infection, Pain, Renal, CNS), by Type (Generic, Innovative), by Type of Manufacturers (In-house, Outsourced) by Synthesis Technology (Solid Phase Peptide Synthesis [SPPS], Liquid Phase Peptide Synthesis [LPPS], Hybrid Technology), and by Route of Administration (Parenteral Route, Oral Route, Pulmonary, Mucosal) – Global Outlook & Forecast 2022-2030" published by Growth Plus Reports, the peptide therapeutics market is expected to grow at a CAGR of 8.2% from 2021 to reach US$ 70.14 billion by 2030. Owing to growing prevalence of chronic diseases and increasing R&D relate to peptide therapeutics.
Download PDF Brochure of Peptide Therapeutics Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://www.growthplusreports.com/inquiry/request-sample/global-peptide-therapeutics-market/8175
Market Drivers
The primary driver factor of the worldwide peptide therapeutics market is the increase in chronic diseases including cancer, cardiovascular disease, and metabolic diseases. The demand for peptide medications is rising as a result of the wide range of therapeutic applications offered by these drugs as well as their low toxicity, efficacy, safety, and tolerability. The market expansion is being significantly influenced by the rising R&D spending on peptide treatment and the existence of a robust pipeline. The major companies are making efforts to create brand-new peptide drug candidates for conditions like diabetes, obesity, infectious disorders, etc. Similarly, the global market is expanding due to the increased technological advancement in peptide manufacture. In addition, the growing number of elderly people leading unhealthy lifestyles and the rising need for affordable medicines are anticipated to support the expansion of the global market.
The global peptide therapeutics market has been analyzed from six perspectives– application, type, type of manufacturers, synthesis technology, route of administration, and region.
Excerpts from ‘By Application Segmentation’
Based on application, the global peptide therapeutics market is segmented into:
- Metabolic
- Cardiovascular Disorder
- Respiratory
- Cancers
- GTI
- Anti-Infection
- Pain
- Renal
- Cns
- Others
The metabolic segment holds the largest market share of the global market in 2021. Due to rising prevalence of metabolic disorders such diabetes, obesity, and kidney illnesses as well as increased investment in the research and development of new peptide medicines for metabolic diseases, the metabolic disorders segment has a significant market share. Similar to this, the growing elderly population, which is more susceptible to metabolic disorders, is promoting the segment's expansion. Growth in this market is being fueled by an increase in unhealthy lifestyles and alcohol and tobacco consumption.
Excerpts from ‘By Type of Manufacturers Segmentation’
Based on the type of manufacturers, the global peptide therapeutics market is categorized into:
- In-House
- Outsourced
The in-house segment dominates the global peptide therapeutics market with the largest market share in 2021. The in-house segment's dominant position can be attributable largely to the rising expense of outscoring, and patent copyright issues are the segment's major driving force. Additionally, the major firms are engaged in the creation of peptide pharmaceuticals since these businesses have a strong infrastructure for the mass production of peptide drugs, which supports the segment's growth.
Request for Customization – https://www.growthplusreports.com/inquiry/customization/global-peptide-therapeutics-market/8175
Excerpts from ‘By Region Segmentation’
Based on region, the global peptide therapeutics market has been segmented into:
- North America
- Europe
- Asia Pacific
- Rest of the World
North America dominated the global peptide therapeutics market in 2021, followed by Europe and Asia Pacific. The main driving factor of regional expansion is the increased frequency of chronic diseases such as cancer, diabetes, and cardiovascular disease according to the American Cancer Society there are an estimated 1.9 million new cancer cases diagnosed in 2022 in U.S. Additionally, the biotech and pharmaceutical sectors are well-established in the region. The presence of research organizations in the region is also assisting in increasing regional growth. Government organizations in the region are investing in peptide medication R&D.
Excerpts from ‘Competitive Landscape’
Some of the prominent players operating in the global Peptide therapeutics market are:
- Pfizer Inc.
- Takeda Pharmaceutical Company Limited
- Eli Lilly and Company
- Amgen Inc.
- Novartis AG
- Sanofi S.A
- Lonza Inc.
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline plc
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- AstraZeneca plc
- Novo Nordisk A/S
- Teva Pharmaceutical Industries Ltd
Table of Content
- INTRODUCTION
-
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2020
- Base Year – 2021
- Forecasted Years – 2022 to 2030
- Currency Used in the Report
- RESEARCH METHODOLOGY
-
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
-
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2021)
- MARKET DYNAMICS
-
- Drivers
- Restraints/Challenges
- Opportunities
- GLOBAL PEPTIDE THERAPEUTICS MARKET - ANALYSIS & FORECAST, BY APPLICATION
-
- Metabolic
- Cardiovascular Disorder
- Respiratory
- Cancers
- GIT
- Anti-infection
- Pain
- Renal
- CNS
- Others
- GLOBAL PEPTIDE THERAPEUTICS MARKET - ANALYSIS & FORECAST, BY TYPE
-
- Generic
- Innovative
TOC Continued….
Global Peptide Therapeutics Market Scope:
| Report Attribute | Details |
| Market size value in 2021 | US$ 34.51 billion |
| Revenue forecast in 2030 | US$ 70.14 billion |
| Growth Rate | CAGR of 8.2% from 2022 to 2030 |
| Base year for estimation | 2021 |
| Forecast period | 2022-2030 |
| Historical Year | 2020 |
| Segments covered | Application, Type, Type of Manufacturers, Synthesis Technology, Route Of Administration, And Region. |
| Regional scope | North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction
Visit our report store at - https://www.growthplusreports.com/report-store
Browse related reports:
Tissue Engineering Market by Material Type (Biologically Derived Material, Synthetic Material, and Others), by Application (Neurology, Orthopedic, Musculoskeletal & Spine, Cardiology & Vascular, Skin & Integumentary, Urology, Dental, Cord Blood & Cell banking, Cancer, and Gynecology) – Global Outlook & Forecast 2022-2030
Cell Therapy Market by Use Type (Clinical Use and Research Use), by Therapy Type (Autologous, and Allogenic), by Therapeutic Area (Malignancies, Musculoskeletal Disorder, Autoimmune Disorder, Dermatology and Other), by End User (Hospital & Clinic and Academic and Research Institute) – Global Outlook & Forecast 2022-2030
Synthetic Biology Market by Product (Enzyme, Synthetic DNA Segment, Cloning Technology Kits), by Technology (PCR and NGS), by Application (Pharmaceuticals & Diagnostics, Healthcare, Chemicals, Biofuels, Bioplastics, and Others) – Global Outlook & Forecast 2022-2030
Heart Blocks Treatment Market by Type (First-degree Heart Blocks, Second-degree Heart Blocks, and Third-degree Heart Blocks), by Treatment (Pacemaker, Transcutaneous pacing (TCP), Medication, and Follow-up electrophysiology study) – Global Outlook & Forecast 2022-2030
Antipsychotic drugs Market By Disorder (Schizophrenia, Bipolar Disorder, Depression, and Dementia), By Drug Class (First-Generation, Second-Generation, and Third Generation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)- Global Outlook & Forecast 2022-2030
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
